Vista Partners Publishes May 2014 Macroeconomic & Investment Newsletter

Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Adtech, Biotechnology, Travel, Energy, Healthcare, Kentucky Derby, Gold, Natural Resources & More


SAN FRANCISCO, CA--(Marketwired - May 2, 2014) - Vista Partners ("Vista") published its FREE Macroeconomic & Investment Monthly Newsletter for the month of May. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst Ross Silver, investment considerations, monthly highlights of each covered company and other broad based commentary. Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Adtech, Biotechnology, Travel, Energy, Healthcare, Kentucky Derby, Gold, Natural Resources & More.

In the May 2014 Macroeconomic & Investment Newsletter, Mr. Silver states, "After a couple of months of disappointing economic data, indicators for March have begun to reflect more robust rates of economic activity. Retail sales posted a sizable 1.1 percent jump for the month, while housing starts and industrial production both posted positive gains in March. What does this mean for equity markets going forward?"

Mr. Silver also states in the newsletter, "As a fun aside, this Saturday features one of the highlights of the thoroughbred racing season, the Kentucky Derby. I correctly predicted the winner of the Kentucky Derby last year and this year am selecting..."

To read more, please download the FREE May 2014 Macroeconomic & Investment Newsletter available at http://www.vistapglobal.com and click "Download Research & Newsletter" to gain access.

The Companies featured in the FREE May 2014 Newsletter are: Adriana Resources, Inc., Accelerize New Media, Inc., Cayden Resources Inc (TSX VENTURE: CYD), Cytosorbents Corporation, Mast Therapeutics, Inc., Ohr Pharmaceutical, Inc. (NASDAQ: OHRP), Soligenix, Inc.(OTCBB: SNGX), Targeted Medical Pharma Inc., Uranerz Energy Corp. (NYSE MKT: URZ) and Power Solutions International Inc. Other companies mentioned are Roche, Novartis, Selexys, Regeneron, Pfizer, OpthoTech Corporation and others.

About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista focuses on investing in and providing investment considerations on publicly traded companies through a platform of stock research reports, newsletters, company specific webpages and daily commentary. The platform of products is meant to serve as potential tools for investors to learn about investment considerations. It is Vista's mission to provide investors with tools that may enable them to make profitable investment decisions with the goal to deliver investment considerations that outperform small, mid and large cap equity indexes. Website: http://www.vistapglobal.com

Please follow us on Twitter @VistaPResearch & Facebook at Vista-Partners to receive updates, thoughts and ideas about and our coverage universe of companies and more.

Disclaimer & Disclosure:
We encourage readers to view a complete list of disclaimers and disclosures on our website: www.vistapglobal.com.

Contact Information:

Contact:
Vista Partners LLC
877.215.4813